CompletedPhase 3NCT00369564
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
Studying Acquired cystic disease-associated renal cell carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of South Florida
- Principal Investigator
- Scott Bradfield, MDNemours Children's Clinic
- Intervention
- glutamic acid(drug)
- Enrollment
- 250 enrolled
- Eligibility
- 3-20 years · All sexes
- Timeline
- 2007 – 2012
Study locations (6)
- Lee Cancer Care of Lee Memorial Health System, Fort Myers, Florida, United States
- Butterworth Hospital at Spectrum Health, Grand Rapids, Michigan, United States
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States
- Hackensack University Medical Center Cancer Center, Hackensack, New Jersey, United States
- Blumenthal Cancer Center at Carolinas Medical Center, Charlotte, North Carolina, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
Collaborators
National Cancer Institute (NCI) · Children's Oncology Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00369564 on ClinicalTrials.govOther trials for Acquired cystic disease-associated renal cell carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06882486Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic TherapyInstitut Paoli-Calmettes
- RECRUITINGPHASE1NCT07517198Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsExscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
- RECRUITINGNANCT06907095Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk IndividualsGustave Roussy, Cancer Campus, Grand Paris
- RECRUITINGNANCT07402109CBCT Guided Markerless SBRT for Renal Cell CancerErasmus Medical Center
- RECRUITINGNANCT07461090Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost AnalysisMenoufia University
- RECRUITINGPHASE1NCT07195682A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)Bristol-Myers Squibb
- RECRUITINGPHASE1NCT07006688A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal ImpairmentServier Bio-Innovation LLC
- RECRUITINGPHASE1, PHASE2NCT07219576Retifanlimab and Ruxolitinib In Solid MalignanciesUniversity of California, San Diego
See all trials for Acquired cystic disease-associated renal cell carcinoma →